Fluconazole with midazolam, amiodarone with digoxin, tube feeds with phenytoin and a ceftriaxone Y-site conflict are the four interactions kept in this MN650 review; weaker software alerts are discarded. Searches like "mn 650 unit 8 assignment example", "mn650 unit 8 sample" and "mn650 unit 8 example" land here.
Ten Infusions Read as One Prescription: A Drug Interaction Review on Day Four After Mitral Valve Repair
[Student Name]
Purdue University Global
MN650: Specialized Pharmacology for the AGACNP Acute Care NP
Unit 8 Assignment
[Instructor Name]
[Date]
Composite patient written as a model document. Doses and changes are bracketed placeholders; nothing here is a prescribing instruction.
The Medication List
A composite 62-year-old accountant, day four after mitral valve repair, still ventilated after a slow wake-up, receiving: norepinephrine at [a composite rate]; propofol at [a composite rate]; midazolam as needed for agitation, about [four] doses a day; fentanyl infusion; amiodarone infusion for post-operative atrial fibrillation; digoxin [a composite dose] daily, started on day two for rate control; fluconazole, started on day three for Candida in a urine culture; phenytoin suspension through the feeding tube, for a seizure disorder since childhood; ceftriaxone for a suspected pneumonia; and a calcium-containing replacement fluid. Continuous tube feeds run at goal.
Interaction 1: Fluconazole and Midazolam
Mechanism: fluconazole inhibits CYP3A4, the enzyme that clears midazolam. Size of effect: fluconazole increases midazolam exposure substantially, more with oral than with intravenous midazolam, and prolongs its sedative effect (Olkkola et al., 1996). What the case shows: he was slow to wake yesterday despite propofol being reduced, and he received three midazolam doses overnight. Proposed change: [stop as-needed midazolam; use propofol adjustment or a nonbenzodiazepine agent for agitation].
This is the interaction most likely to harm him soon, because prolonged sedation would delay extubation and cloud the neurologic checks that follow cardiac surgery.
Interaction 2: Amiodarone and Digoxin
Mechanism: amiodarone inhibits P-glycoprotein and reduces the renal and nonrenal clearance of digoxin. Size of effect: digoxin levels can roughly double; both product labels advise reducing the digoxin dose substantially when amiodarone is started. What the case shows: digoxin was started on day two at a standard dose, after amiodarone was already running. Proposed change: [reduce digoxin by about half and check a level after a composite interval]; watch for bradycardia and new arrhythmias.
Interaction 3: Tube Feeds and Phenytoin
Mechanism: continuous enteral feeds bind phenytoin suspension and sharply reduce its absorption. Size of effect: in a small study, continuous nasogastric feeding markedly lowered phenytoin levels, which rose again when feeds were held around doses (Bauer, 1982). What the case shows: his last total phenytoin level was low at [a composite value], and his albumin is 2.6 g/dL, so the total level may also understate the free fraction. Proposed change: [hold feeds for a composite interval before and after each dose]; request a free phenytoin level.
Interaction 4: Ceftriaxone and Calcium
Mechanism: ceftriaxone and calcium can form a precipitate. Size of effect: this is a physical incompatibility, not a change in drug levels; it is a hazard whenever both run through the same line at the same time. What the case shows: both are running, with the replacement fluid through the same central lumen as ceftriaxone for part of the day. Proposed change: [separate lumens, or flush the line between infusions and never run them simultaneously].
Hemodynamic Interplay
Propofol lowers blood pressure by relaxing blood vessels and reducing cardiac output. His norepinephrine requirement rose each time propofol was increased yesterday. That is an interaction in the plainest sense, and reducing propofol as sedation needs fall, and removing midazolam, may lower his vasopressor need.
Alerts Judged Minor
The electronic record raised six further alerts, each judged minor for this patient:
1. Fentanyl and midazolam, additive sedation: already addressed by Interaction 1.
2. Amiodarone and fentanyl, possible CYP3A4 effect: small for intravenous fentanyl at his dose, with sedation monitored.
3. Fluconazole and amiodarone, QT prolongation: his QTc is 450 ms and checked daily; noted, not changed.
4. Ceftriaxone and phenytoin, protein binding: small effect, covered by the free level.
5. Digoxin and calcium, arrhythmia risk: his calcium is normal and the replacement is small.
6. Norepinephrine and amiodarone, blood pressure: expected and monitored.
Dismissing these matters as much as keeping the four above. When every combination is flagged, clinicians learn to override alerts, and important warnings are overridden with the trivial ones (van der Sijs et al., 2006). The review is sent to the pharmacist and the bedside team with the four changes at the top, so that the actions are seen before the explanations.
References
Bauer, L. A. (1982). Interference of oral phenytoin absorption by continuous nasogastric feedings. Neurology, 32(5), 570-572. https://doi.org/10.1212/WNL.32.5.570
Olkkola, K. T., Ahonen, J., & Neuvonen, P. J. (1996). The effect of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam. Anesthesia & Analgesia, 82(3), 511-516. https://doi.org/10.1097/00000539-199603000-00015
van der Sijs, H., Aarts, J., Vulto, A., & Berg, M. (2006). Overriding of drug safety alerts in computerized physician order entry. Journal of the American Medical Informatics Association, 13(2), 138-147. https://doi.org/10.1197/jamia.M1809
How this MN650 Unit 8 example is structured
Consequence organizes the review, not the alphabet or a severity rating. The first interaction discussed is the likeliest to harm this patient soon: prolonged sedation from midazolam that a fluconazole course has made harder to clear, which would delay extubation and cloud a neurologic check. Each block keeps the same order so that mechanism, magnitude and evidence can be compared across very different problems. Magnitude is where the paper earns its credit, separating an interaction that changes exposure several-fold from one that shifts it slightly instead of repeating a software severity tier. Hemodynamic interplay gets a paragraph of its own, since propofol's vasodilation raises the norepinephrine requirement and that is an interaction in the plainest sense. The dismissed alerts matter as much as the retained ones, because alert fatigue is a genuine hazard and a list that flags everything protects no one.
Get an MN650 Unit 8 example written to your instructions
Send the full medication list from your MN650 Unit 8 case, infusions, tube medications and fluids included, with the rubric. Free to a first-time requester and usually ready inside 24-48h, the review reads every order as part of a single prescription, weighs each interaction by size and relevance, and explains openly which alerts it sets aside and why. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
MN650 Unit 8 questions, answered
Should the review include every interaction software finds?
It should account for them without treating them equally. The sample discusses the few that matter for this patient in depth and lists the rest with a brief reason each was judged minor. Markers generally reward that judgment; a review that simply reproduces an alert list shows that the software worked, not that the writer thought.
Which interaction references are acceptable?
Primary pharmacokinetic studies, the product labels and a recognized drug interaction reference all hold up. The sample cites the label when a label states a specific adjustment and a study when the magnitude is the question. Interaction checkers are fine for finding candidates but weak as the sole citation for a clinical decision.
Is physical compatibility really part of pharmacology?
In an acute care course, usually yes. When several infusions share limited access, a precipitate at a Y-site can block a line or harm the patient, and that risk depends on the drugs themselves. The sample treats it as an interaction like any other, naming the source, usually a compatibility reference or the product label.